HOLLY: “Pushing Through Resistance” Leads 16 Other Trade Ideas

HOLLY  |

“Pushing Through Resistance” Leads The Daily Regime of Optimized Algorithms

Good morning. “‘Pushing Through Resistance’, today’s high performing algorithm, headlines the Holly Morning Huddle Report.”

As of today, Thursday, August 30, 2018, the return from my trading performance since January 1 stands at +76.1 accumulated profit points vs the benchmark SPY’s performance of +19.4 points over the same period. On Wednesday my performance was higher +2.0 in Risk-Off mode (shown above). Risk-Off mode is where trades are not extended and exits are bounded by predetermined time in trade limits absent other reasons to exit (e.g., price target or stop loss reached, etc.) On Wednesday, the SPY was up +1.6. My Risk-On mode, which extends the holding period for trades until the day’s close, was up +4.3 points.

61 stocks traded yesterday: 52 long and 9 stocks traded short in the following sectors. 24/61 were in the Manufacturing sector.

Today’s a new day and I am prepared for the market open with 17 themes/strategies I determined overnight will best match what the market throws at us. I may or may not use all these intraday strategies depending on whether or not all the criteria for each are satisfied.

Of these 17 strategies selected today 13 are Long, bullish in outlook. 4 are Short, bearish in outlook. Ready for anything. The Pushing Through Resistance strategy, in the list below, has the highest Win % heading into the Open based on optimized, backtested scenarios.

Here are the algos:

No. Win% Strategy L/S
1 68.9 Bon Shorty Short
2 67.5 Breakout Long
3 69 Bullish Pullback Long
4 61.4 Count De Monet Long
5 70.6 Downward Dog Short
6 59.4 Got Dough Wants To Go Long
7 62.3 Little Big Guy Long
8 70.7 Looking for Bounce Long
9 70.2 Power Hour Short Short
10 71 Pushing Through Resistance Long
11 62.3 Putting on the Breaks Short
12 61.1 Quarterback Long
13 63.6 Strong Stock Pulling Back Long
14 60 Sunrise Mover Long
15 60 Tailwind Long
16 68.6 The 5 Day Bounce Long
17 62.8 The Continuation Long

Have a great morning. See you in the markets!

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.